Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Halamka

Showing results (51-60 of 64) with videos related to

Pageof 7
Sort By:
Medrxiv : the Preprint Server for Health Sciences|August 17, 2021
Comparison of two highly-effective mRNA vaccines for COVID-19 during periods of Alpha and Delta variant prevalenceArjun Puranik, Patrick J Lenehan, Eli Silvert, et al.
PLOS Digital Health|February 22, 2023
Best practices in the real-world data life cycleJoe Zhang, Joshua Symons, Paul Agapow, et al.
Circulation|December 22, 2016
Recommendations for the Implementation of Telehealth in Cardiovascular and Stroke Care: A Policy Statement From the American Heart AssociationLee H Schwamm, Neale Chumbler, Ed Brown, et al.
NPJ Digital Medicine|July 28, 2021
Mapping each pre-existing condition's association to short-term and long-term COVID-19 complicationsA J Venkatakrishnan, Colin Pawlowski, David Zemmour, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|October 10, 2021
Cerebral Venous Sinus Thrombosis is not Significantly Linked to COVID-19 Vaccines or Non-COVID Vaccines in a Large Multi-State Health SystemColin Pawlowski, John Rincón-Hekking, Samir Awasthi, et al.
JAMA Network Open|November 2, 2021
Analysis of the Effectiveness of the Ad26.COV2.S Adenoviral Vector Vaccine for Preventing COVID-19Juan Corchado-Garcia, David Zemmour, Travis Hughes, et al.
Med (New York, N.Y.)|December 20, 2021
Comparative effectiveness of mRNA-1273 and BNT162b2 against symptomatic SARS-CoV-2 infectionArjun Puranik, Patrick J Lenehan, Eli Silvert, et al.
Scientific Reports|January 5, 2023
Expanding repertoire of SARS-CoV-2 deletion mutations contributes to evolution of highly transmissible variantsA J Venkatakrishnan, Praveen Anand, Patrick J Lenehan, et al.
Cell Death Discovery|March 16, 2021
Plasma IL-6 levels following corticosteroid therapy as an indicator of ICU length of stay in critically ill COVID-19 patientsSamir Awasthi, Tyler Wagner, A J Venkatakrishnan, et al.
Elife|August 18, 2020
Inference from longitudinal laboratory tests characterizes temporal evolution of COVID-19-associated coagulopathy (CAC)Colin Pawlowski, Tyler Wagner, Arjun Puranik, et al.
Pageof 7

Showing results (51-60 of 64) with videos related to

Sort By:
Pageof 7
Medrxiv : the Preprint Server for Health Sciences|August 17, 2021
Comparison of two highly-effective mRNA vaccines for COVID-19 during periods of Alpha and Delta variant prevalenceArjun Puranik, Patrick J Lenehan, Eli Silvert, et al.
PLOS Digital Health|February 22, 2023
Best practices in the real-world data life cycleJoe Zhang, Joshua Symons, Paul Agapow, et al.
Circulation|December 22, 2016
Recommendations for the Implementation of Telehealth in Cardiovascular and Stroke Care: A Policy Statement From the American Heart AssociationLee H Schwamm, Neale Chumbler, Ed Brown, et al.
NPJ Digital Medicine|July 28, 2021
Mapping each pre-existing condition's association to short-term and long-term COVID-19 complicationsA J Venkatakrishnan, Colin Pawlowski, David Zemmour, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|October 10, 2021
Cerebral Venous Sinus Thrombosis is not Significantly Linked to COVID-19 Vaccines or Non-COVID Vaccines in a Large Multi-State Health SystemColin Pawlowski, John Rincón-Hekking, Samir Awasthi, et al.
JAMA Network Open|November 2, 2021
Analysis of the Effectiveness of the Ad26.COV2.S Adenoviral Vector Vaccine for Preventing COVID-19Juan Corchado-Garcia, David Zemmour, Travis Hughes, et al.
Med (New York, N.Y.)|December 20, 2021
Comparative effectiveness of mRNA-1273 and BNT162b2 against symptomatic SARS-CoV-2 infectionArjun Puranik, Patrick J Lenehan, Eli Silvert, et al.
Scientific Reports|January 5, 2023
Expanding repertoire of SARS-CoV-2 deletion mutations contributes to evolution of highly transmissible variantsA J Venkatakrishnan, Praveen Anand, Patrick J Lenehan, et al.
Cell Death Discovery|March 16, 2021
Plasma IL-6 levels following corticosteroid therapy as an indicator of ICU length of stay in critically ill COVID-19 patientsSamir Awasthi, Tyler Wagner, A J Venkatakrishnan, et al.
Elife|August 18, 2020
Inference from longitudinal laboratory tests characterizes temporal evolution of COVID-19-associated coagulopathy (CAC)Colin Pawlowski, Tyler Wagner, Arjun Puranik, et al.
Pageof 7